Nektar Therapeutics NKTR incurred an adjusted loss per share of 15 cents in the fourth quarter of 2024, wider than the Zacks ...

Analysts have been eager to weigh in on the Energy sector with new ratings on EOG Resources (EOG – Research Report) and Pembina Pipeline (PBA ...

Novo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate, CagriSema. Roche RHHBY ...

Charles Schwab Investment Management Inc. boosted its stake in Pembina Pipeline Co. (NYSE:PBA – Free Report) (TSE:PPL) by 2.6 ...

Terns Pharmaceuticals is a small-cap biotech with a couple of weight loss candidates in its pipeline. The stock's price ...

Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...

The Internal Revenue Service (IRS) has already processed more than 29.6 million tax refunds this year, up 2.3% from last year ...

Passive income investors looking to get paid to navigate a more turbulent stock market should look to the many dividend ...

There is a healthy pipeline of U.S. initial public offerings, but investors are looking for more certainty in markets, Adena ...

Additional Phase 2 data for vilastobart,a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with atezolizumab in patients with MSS CRC ...